DelveInsight has launched a new report on Blepharitis Pipeline
“Blepharitis is an inflammation of the eyelids in which they become red, irritated, itchy, and dandruff-like scales form on the eyelashes”. It is a chronic external eye disorder resulting in red, burning, and irritated eyes which does not cause serious damage to the eyes, but it can be very uncomfortable. It can be caused by either bacteria or a skin condition, such as dandruff of the scalp or rosacea.
Browse for free sample copy- https://www.delveinsight.com/sample-request/blepharitis-pipeline-insight
Blepharitis Pipeline analysis across different stages of development (Phase III & Phase II), different emerging trends and comparative analysis of Blepharitis pipeline products with detailed clinical profiles, key cross -competition, launch date along with product development activities.
Blepharitis Pipeline
Blepharitis on the basis of anatomic location is of three types: Anterior Blepharitis, Posterior Bepharitis, and Mixed Anterior and Posterior Blepharitis. Anterior Blepharitis affects the front of the eyelids around the eyelashes and may be due to seborrhoeic dermatitis, may also involve the scalp, face and ears, or be due to bacterial (staphylococcal) infection. Posterior Blepharitis mainly affects the back of the eyelids, around the Meibomian glands, often associated with rosacea. Mixed anterior and posterior blepharitis is a combination of both anterior and posterior blepharitis.
Emerging therapies included in the report
Blepharitis Treatment
Early diagnosis and appropriate treatment can prevent disfigurement and may be lifesaving for this condition. A paradigm shift appears to be occurring in the treatment of Blepharitis. Whereas traditionally warm compress therapy and antibiotic ointment application have been the mainstays of treatment, however, many clinicians are now using prescription antibiotic therapy, as a treatment foundation. Targeting the important pathologic factors- bacteria, inflammation, and meibomian gland dysfunction- is critical to the successful management of Blepharitis.
Blepharitis Report Scope
Table of content
1. Report Introduction
2. Blepharitis
3. Blepharitis Current Treatment Patterns
4. Blepharitis – DelveInsight’s Analytical Perspective
5. Therapeutic Assessment
6. Blepharitis Late Stage Products (Phase-III)
7. Blepharitis Mid Stage Products (Phase-II)
8. Early Stage Products (Phase-I)
9. Pre-clinical Products and Discovery Stage Products
10. Inactive Products
11. Dormant Products
12. Blepharitis Discontinued Products
13. Blepharitis Product Profiles
14. Blepharitis Key Companies
15. Blepharitis Key Products
16. Dormant and Discontinued Products
17. Blepharitis Unmet Needs
18. Blepharitis Future Perspectives
19. Blepharitis Analyst Review
20. Appendix
21. Report Methodology
What are the report highlights?
Related Reports
Media ContactCompany Name: DelveInsight Business Research LLPContact Person: Yash BhardwajEmail: Send EmailPhone: +919650213330Address:304 S. Jones Blvd #2432 City: Las VegasState: NVCountry: United StatesWebsite: https://www.delveinsight.com/